Learn more about this common disorder of neuromuscular transmission and its affects on patients
Technology
Our Editor-in-Chief tells the story of her experience as a patient.
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…
On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain four strains…
On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in principle on…
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled because of…
On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of…
The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and…
It never fails — you waited all year for a special holiday party, and the day of the party, you feel chills, a headache,…
Pharmacomechanical thrombectomy removes dangerous clots to restore healthy function in hours.
The U.S. Food and Drug administration has approved the first generic version of Lipitor (atorvastatin calcium). Read more.
ECRI Institute’s top 10 health technology hazards for 2012 include alarm hazards, medication errors when using infusion pumps, enteral feeding misconnections, and cross-contamination from…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement…
FDA approves first quadrivalent vaccine to prevent seasonal influenza
On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain…
FDA announces agreement in principle on medical device user fees
On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in…
FDA announces guidelines for polymyxin, vecuronium recall
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled…
U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)
On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate…
FDA approves expanded use of Prevnar vaccine
The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50…
Seasonal flu, the holidays, and you: An update on the 2011-12 flu season
It never fails — you waited all year for a special holiday party, and the day of the party, you feel chills,…
New minimally invasive technique treats acute DVT
Pharmacomechanical thrombectomy removes dangerous clots to restore healthy function in hours.
FDA approves first generic version of Lipitor
The U.S. Food and Drug administration has approved the first generic version of Lipitor (atorvastatin calcium). Read more.
ECRI names top 10 health technology hazards for 2012
ECRI Institute’s top 10 health technology hazards for 2012 include alarm hazards, medication errors when using infusion pumps, enteral feeding misconnections, and…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.